Rita D. Brandão
Rita D. Brandão
Verified email at
Cited by
Cited by
Next-generation sequencing in oncology: genetic diagnosis, risk prediction and cancer classification
R Kamps, RD Brandão, BJ van den Bosch, ADC Paulussen, ...
International journal of molecular sciences 18 (2), 308, 2017
A guide for functional analysis of BRCA1 variants of uncertain significance
GA Millot, MA Carvalho, SM Caputo, MPG Vreeswijk, MA Brown, M Webb, ...
Human mutation 33 (11), 1526-1537, 2012
Screening for a BRCA2 rearrangement in high-risk breast/ovarian cancer families: evidence for a founder effect and analysis of the associated phenotypes
PM Machado, RD Brandao, BM Cavaco, J Eugénio, S Bento, M Nave, ...
Journal of clinical oncology 25 (15), 2027-2034, 2007
A randomised controlled phase II trial of pre-operative celecoxib treatment reveals anti-tumour transcriptional response in primary breast cancer
RD Brandão, J Veeck, KK Van de Vijver, P Lindsey, B De Vries, ...
Breast cancer research 15, 1-12, 2013
Comprehensive annotation of splice junctions supports pervasive alternative splicing at the BRCA1 locus: a report from the ENIGMA consortium
M Colombo, MJ Blok, P Whiley, M Santamarina, S Gutierrez-Enriquez, ...
Human molecular genetics 23 (14), 3666-3680, 2014
Emerging importance of chemokine receptor CXCR3 and its ligands in cardiovascular diseases
R Altara, M Manca, RD Brandão, A Zeidan, GW Booz, FA Zouein
Clinical science 130 (7), 463-478, 2016
Phylogenomics of the major tropical plant family Annonaceae using targeted enrichment of nuclear genes
TLP Couvreur, AJ Helmstetter, EJM Koenen, K Bethune, RD Brandão, ...
Frontiers in plant science 9, 431757, 2019
Comparison of mRNA splicing assay protocols across multiple laboratories: recommendations for best practice in standardized clinical testing
PJ Whiley, M De La Hoya, M Thomassen, A Becker, R Brandão, ...
Clinical chemistry 60 (2), 341-352, 2014
Naturally occurring BRCA2 alternative mRNA splicing events in clinically relevant samples
JD Fackenthal, T Yoshimatsu, B Zhang, GR de Garibay, M Colombo, ...
Journal of medical genetics 53 (8), 548-558, 2016
Targeted RNA‐seq successfully identifies normal and pathogenic splicing events in breast/ovarian cancer susceptibility and Lynch syndrome genes
RD Brandão, K Mensaert, I López‐Perolio, D Tserpelis, M Xenakis, ...
International journal of cancer 145 (2), 401-414, 2019
Characterisation of unclassified variants in the BRCA1/2 genes with a putative effect on splicing
RD Brandao, K van Roozendaal, D Tserpelis, EG García, MJ Blok
Breast cancer research and treatment 129, 971-982, 2011
Full in-frame exon 3 skipping of BRCA2 confers high risk of breast and/or ovarian cancer
SM Caputo, M Léoné, F Damiola, A Ehlen, A Carreira, P Gaidrat, ...
Oncotarget 9 (25), 17334, 2018
Familial Breast/Ovarian Cancer and BRCA1/2 Genetic Screening: The Role of Immunohistochemistry as an Additional Method in the Selection of Patients
FH Vaz, PM Machado, RD Brandao, CT Laranjeira, JS Eugenio, ...
Journal of Histochemistry & Cytochemistry 55 (11), 1105-1113, 2007
Efficiency of BRCAPRO and Myriad II mutation probability thresholds versus cancer history criteria alone for BRCA1/2 mutation detection
JJT Van Harssel, CEP van Roozendaal, Y Detisch, RD Brandao, ...
Familial cancer 9, 193-201, 2010
Pathogenic neurofibromatosis type 1 (NF1) RNA splicing resolved by targeted RNAseq
R Koster, RD Brandão, D Tserpelis, CEP van Roozendaal, ...
NPJ genomic medicine 6 (1), 95, 2021
Correlated evolutionary rates across genomic compartments in Annonaceae
PH Hoekstra, JJ Wieringa, E Smets, RD Brandão, J de Carvalho Lopes, ...
Molecular phylogenetics and evolution 114, 63-72, 2017
Parent-of-origin specific linkage and association of the IGF2 gene region with birth weight and adult metabolic risk factors
NY Souren, ADC Paulussen, A Steyls, RJF Loos, RD Brandao, M Gielen, ...
International journal of obesity 33 (9), 962-970, 2009
In Silico Analysis of Differential Gene Expression in Three Common Rat Models of Diastolic Dysfunction
R Altara, FA Zouein, RD Brandão, SN Bajestani, A Cataliotti, GW Booz
Frontiers in cardiovascular medicine 5, 11, 2018
FMR1 low sub-genotype does not rescue BRCA1/2-mutated human embryos and does not explain primary ovarian insufficiency among BRCA1/2-carriers
RD Brandão, K van Roozendaal, D Tserpelis, MJ Blok
Human Reproduction 28 (8), 2308-2311, 2013
Clinical, splicing, and functional analysis to classify BRCA2 exon 3 variants: Application of a points‐based ACMG/AMP approach
M Thomassen, RLS Mesman, TVO Hansen, M Menendez, M Rossing, ...
Human mutation 43 (12), 1921-1944, 2022
The system can't perform the operation now. Try again later.
Articles 1–20